Exact Sciences News

60,58 -1,53% -0,94 €
08:00:53 Uhr Stuttgart | Mehr Kurse »
WKN: 590273
ISIN: US30063P1057
US-Symbol: EXAS
Typ: Aktie

Exact Sciences News

  
09.11.18 Exact Sciences to participate in two November investor conferences PR Newswire
30.10.18 Cologuard® revenue increased 63 percent to $118 million, and Cologuard test volume grew 49 percent to 241,000 during third quarter PR Newswire
24.10.18 3 Aktien, die binnen 10 Jahren 1.000 USD in 23.000 USD (und mehr) verwandelt haben The Motley Fool
18.10.18 Exact Sciences Strengthens Pipeline Capabilities with Acquisition of Biomatrica, a Leading Provider of Biological Sample Preservation Technology PR Newswire
08.10.18 Exact Sciences schedules third-​quarter 2018 earnings call PR Newswire
31.08.18 Exact Sciences to participate in September investor conferences PR Newswire
23.08.18 Rallye-​Alarm bei Exact Sciences: 50 Prozent in zwei Tagen - Shortsqueeze! Der Aktionär
22.08.18 Kursexplosion um 30 Prozent nach Hammer-​Deal: Pfizer setzt auf Exact-​Test Der Aktionär
22.08.18 Exact Sciences to host conference call and webcast to discuss its Cologuard co-​promotion agreement with Pfizer PR Newswire
22.08.18 Exact Sciences and Pfizer Enter into U.S. Promotion Agreement for Cologuard® PR Newswire
13.08.18 Green Bay Packers and Cologuard Launch "Crossing the 50" Colon Cancer Awareness Campaign PR Newswire
06.08.18 Exact Sciences to participate in Canaccord Genuity Growth Conference PR Newswire
02.08.18 Tom Lehman Joins Forces with Fight Colorectal Cancer to Raise Awareness of Nation's Second-​Leading Cause of Cancer Deaths PR Newswire
02.08.18 Epigenomics-​Rivale Exact Sciences: Wenn knapp 80 Prozent Wachstum nicht reichen... Der Aktionär
01.08.18 Cologuard® revenue increased 78 percent to $103 million during second quarter PR Newswire
09.07.18 Exact Sciences to host annual meeting, second-​quarter 2018 results webcasts and calls PR Newswire
26.06.18 Nurse Practitioners are Critical Source of Colorectal Cancer Screening Information for Patients, Survey Shows PR Newswire
19.06.18 Cologuard Challenge Expands to AmFam Championship Urging PGA TOUR Champions Fans to Get Screened for Colon Cancer PR Newswire
08.06.18 Exact Sciences Announces Upsizing and Pricing of 1.0% Convertible Senior Notes Due 2025 PR Newswire
07.06.18 Exact Sciences Announces Offering of 1.0% Convertible Senior Notes Due 2025 PR Newswire
05.06.18 Exact Sciences, Mayo Clinic Researchers Identify Blood-​Based DNA Biomarker Panel to Accurately Diagnose Hepatocellular Carcinoma PR Newswire
01.06.18 Exact Sciences to participate in June investor conferences PR Newswire
01.06.18 Blutbad bei Epigenomics: Horror-​Nachricht aus den USA Der Aktionär
30.05.18 Exact Sciences Applauds American Cancer Society's Updated Colorectal Cancer Screening Guidelines to Include People Age 45-49 PR Newswire
03.05.18 Vince Lombardi Cancer Foundation and Exact Sciences Team Up to Fight Colon Cancer PR Newswire
01.05.18 Exact Sciences to participate in two investor conferences during May PR Newswire
30.04.18 Must See Stock Score Reports for Charter Communications, Exact Sciences, Nike, Sprint, and Snap Inc. PR Newswire
26.04.18 Cologuard® revenue and completed tests increased 87 percent to $90.3 million and 186,000 PR Newswire
09.04.18 Exact Sciences schedules first-​quarter 2018 earnings call PR Newswire
20.03.18 Mark Stenhouse to join Exact Sciences as President, Cologuard PR Newswire
19.03.18 Harry Connick, Jr. and Wife and Cancer Survivor Jill Connick Team Up to Urge People 50 and Older to Get Screened for Colon Cancer PR Newswire
06.03.18 Mayo Clinic's Dr. Paul Limburg to join Exact Sciences medical leadership PR Newswire
01.03.18 Jerry Kelly Issues Cologuard Challenge, Urging Fellow PGA TOUR Champions Players to Get Screened for Colon Cancer PR Newswire
01.03.18 Exact Sciences to participate in March investor conferences PR Newswire
28.02.18 Tucson Conquistadores and Cologuard Present Check to Vince Lombardi Cancer Foundation PR Newswire
26.02.18 More than 1 Million Screened for Colorectal Cancer with Cologuard PR Newswire
22.02.18 Cologuard® revenue increased 168 percent to $266 million PR Newswire
08.02.18 Exact Sciences schedules fourth-​quarter, full-year 2017 earnings call PR Newswire
01.02.18 Exact Sciences to participate in Leerink Partners 7th Annual Global Healthcare Conference PR Newswire
11.01.18 Exact Sciences Announces Offering of $500 Million Convertible Senior Notes Due 2025 PR Newswire
11.01.18 Exact Sciences Announces Upsize and Pricing of $600 Million of 1.0% Convertible Senior Notes Due 2025 PR Newswire
10.01.18 Attacke auf Epigenomics: Exact wächst kräftig und entwickelt neue Tests Der Aktionär
07.01.18 Exact Sciences to report $265.5-266.5 million in revenue, 168 percent growth for 2017 PR Newswire
20.12.17 Exact Sciences to participate in J.P. Morgan Healthcare Conference PR Newswire
08.12.17 Wo steht Exact Sciences in 5 Jahren? The Motley Fool
05.12.17 Warum 2017 war ein denkwürdiges Jahr für Exact Sciences Corporation war The Motley Fool
13.11.17 Hot-Stock Exact: 25% in fünf Wochen - Ende der Fahnenstange? Der Aktionär
08.11.17 Exact Sciences to Expand Laboratory and Corporate Facilities in Madison PR Newswire
05.11.17 Exact Sciences: Dem Krebs auf der Spur Der Aktionär
02.11.17 Exact Sciences to participate in two investor conferences during November PR Newswire

Newssuche